诺和诺德将以每股54美元现金收购Akero Therapeutics_老虎社区_美港股上老虎

诺和诺德将以每股54美元现金收购Akero Therapeutics

老虎资讯综合10-09

10月9日，Akero Therapeutics美股盘前涨超16%！报道称诺和诺德将以每股54美元现金收购Akero Therapeutics。诺和诺德表示该交易预计不会影响2025财年营业利润展望；诺和诺德盘前一度跌近2%。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

静舒
·10-09
这公司相当垃圾，为啥收购这个？？？？上次刚被骗完
回复
1
举报

热议股票

7x24

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1130478889?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e","is_english":false,"pubTime":"2025-10-09 18:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1130478889","market":"us","top_or_hot":-1,"title":"诺和诺德将以每股54美元现金收购Akero Therapeutics","media":"老虎资讯综合","content":"<html><head></head><body><p>10月9日，<a href=\"https://laohu8.com/S/AKRO\">Akero Therapeutics</a>美股盘前涨超16%！报道称<a href=\"https://laohu8.com/S/NVO\">诺和诺德</a>将以每股54美元现金收购Akero <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>。诺和诺德表示该交易预计不会影响2025财年营业利润展望；诺和诺德盘前一度跌近2%。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/29d68236a17ee65f355ddaf42e92d6b2\" title=\"\" tg-width=\"837\" tg-height=\"834\"/></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3db97a2ca817095bcc3d901cb99103db\" title=\"\" tg-width=\"834\" tg-height=\"825\"/></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>诺和诺德将以每股54美元现金收购Akero Therapeutics</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n诺和诺德将以每股54美元现金收购Akero Therapeutics\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2025-10-09 18:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>10月9日，<a href=\"https://laohu8.com/S/AKRO\">Akero Therapeutics</a>美股盘前涨超16%！报道称<a href=\"https://laohu8.com/S/NVO\">诺和诺德</a>将以每股54美元现金收购Akero <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>。诺和诺德表示该交易预计不会影响2025财年营业利润展望；诺和诺德盘前一度跌近2%。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/29d68236a17ee65f355ddaf42e92d6b2\" title=\"\" tg-width=\"837\" tg-height=\"834\"/></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3db97a2ca817095bcc3d901cb99103db\" title=\"\" tg-width=\"834\" tg-height=\"825\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4599","symbol_name":"减肥药","start_time":0,"source_url":"","article_id":"1130478889","we_media_id":"102","thumbnails":["https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1130478889","pubTimestamp":1760004404,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"老虎资讯综合","introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"summary":"10月9日，$Akero Therapeutics(AKRO)$美股盘前涨超16%！报道称$诺和诺德(NVO)$将以每股54美元现金收购Akero $Therapeutics(LENZ)$。诺和诺德盘前一度跌近2%。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4599":"减肥药","LENZ":"Therapeutics","NVO":"诺和诺德","AKRO":"Akero Therapeutics","BK4007":"制药","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","LU0154236417.USD":"BGF US FLEXIBLE EQUITY \"A2\" ACC","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","BK4588":"碎股","BK4539":"次新股","BK4505":"高瓴资本持仓","BK4585":"ETF&股票定投概念","BK4139":"生物科技","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","BK4532":"文艺复兴科技持仓"},"translate_title":"Market News: Novo Nordisk to acquire Akero Therapeutics for $54 per share in cash","themeId":"7634fea479edb90013bb48394ae3ce34","isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/c1f605d2bc54fae4d3179582a52ba9b6","symbols_score_info":{"AKRO":1.5,"LENZ":1.5,"NVO":1.5},"content_text":"10月9日，Akero Therapeutics美股盘前涨超16%！报道称诺和诺德将以每股54美元现金收购Akero Therapeutics。诺和诺德表示该交易预计不会影响2025财年营业利润展望；诺和诺德盘前一度跌近2%。","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[{"id":487327008563640,"gmtCreate":1760005201648,"gmtModify":1760005489160,"author":{"id":"3549529768039029","authorId":"3549529768039029","name":"静舒","avatar":"https://static.tigerbbs.com/cb256ffabe33175e8c258c5d6464d3e5","vip":1,"hat":"https://static.tigerbbs.com/e379cae6dff6a66d464cfdb7021903eb","crmLevel":5,"crmLevelSwitch":0,"idStr":"3549529768039029","authorIdStr":"3549529768039029"},"htmlText":"这公司相当垃圾，为啥收购这个？？？？上次刚被骗完","listText":"这公司相当垃圾，为啥收购这个？？？？上次刚被骗完","text":"这公司相当垃圾，为啥收购这个？？？？上次刚被骗完","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/487327008563640","repostId":1130478889,"repostType":2,"repost":{"id":"1130478889","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1760004404,"share":"https://www.laohu8.com/m/news/1130478889?lang=&edition=full","pubTime":"2025-10-09 18:06","market":"us","language":"zh","title":"诺和诺德将以每股54美元现金收购Akero Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=1130478889","media":"老虎资讯综合","summary":"10月9日，$Akero Therapeutics(AKRO)$美股盘前涨超16%！报道称$诺和诺德(NVO)$将以每股54美元现金收购Akero $Therapeutics(LENZ)$。诺和诺德盘前一度跌近2%。","content":"<html><head></head><body><p>10月9日，<a href=\"https://laohu8.com/S/AKRO\">Akero Therapeutics</a>美股盘前涨超16%！报道称<a href=\"https://laohu8.com/S/NVO\">诺和诺德</a>将以每股54美元现金收购Akero <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>。诺和诺德表示该交易预计不会影响2025财年营业利润展望；诺和诺德盘前一度跌近2%。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/29d68236a17ee65f355ddaf42e92d6b2\" title=\"\" tg-width=\"837\" tg-height=\"834\"/></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3db97a2ca817095bcc3d901cb99103db\" title=\"\" tg-width=\"834\" tg-height=\"825\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>诺和诺德将以每股54美元现金收购Akero Therapeutics</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n诺和诺德将以每股54美元现金收购Akero Therapeutics\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2025-10-09 18:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>10月9日，<a href=\"https://laohu8.com/S/AKRO\">Akero Therapeutics</a>美股盘前涨超16%！报道称<a href=\"https://laohu8.com/S/NVO\">诺和诺德</a>将以每股54美元现金收购Akero <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>。诺和诺德表示该交易预计不会影响2025财年营业利润展望；诺和诺德盘前一度跌近2%。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/29d68236a17ee65f355ddaf42e92d6b2\" title=\"\" tg-width=\"837\" tg-height=\"834\"/></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3db97a2ca817095bcc3d901cb99103db\" title=\"\" tg-width=\"834\" tg-height=\"825\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e","relate_stocks":{"BK4599":"减肥药","LENZ":"Therapeutics","NVO":"诺和诺德","AKRO":"Akero Therapeutics","BK4007":"制药","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","LU0154236417.USD":"BGF US FLEXIBLE EQUITY \"A2\" ACC","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","BK4588":"碎股","BK4539":"次新股","BK4505":"高瓴资本持仓","BK4585":"ETF&股票定投概念","BK4139":"生物科技","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","BK4532":"文艺复兴科技持仓"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1130478889","content_text":"10月9日，Akero Therapeutics美股盘前涨超16%！报道称诺和诺德将以每股54美元现金收购Akero Therapeutics。诺和诺德表示该交易预计不会影响2025财年营业利润展望；诺和诺德盘前一度跌近2%。","news_type":1,"symbols_score_info":{"AKRO":1.5,"LENZ":1.5,"NVO":1.5}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":1,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}